CHLA Clinical Research Studies

Having volunteers participate in research studies and clinical trials is critical to our research efforts. Thousands of children and families are involved in our patient-centered studies every year. Many of the treatments used today are based on the results of past research studies and clinical trials conducted with our patients. Our scientific and clinical experts take the best ideas from the laboratory -- to the patient -- in the form of promising new treatments.

By searching our study directory, you may identify research that could impact the life of your child or of another child you know. Because the number of available research studies and clinical trials for children nationwide is small, every participant makes a significant contribution.

In addition to enrolling children with certain diseases in order to study treatments and prevention of those diseases, we also need to study healthy children. Ask your child’s doctor about volunteer study options that may be suitable for your child.

Please contact the study staff listed in your search results for more information.

Search by Keyword:    

Back to the full listing

Study Details - ID: CCI-06-00198
Health/Science/Disease Category:
Oncology
Short Name:
Tumor Registry
Full Title of Study:
CHLA Tumor Registry
Phase/Type of Study:
Registry / Repository
Purpose of Research:
The primary aim of this registry will be to identify genes and/or biologic and environmental factors that either cause these tumors or increase one's risk for developing them. Ultimately, research using this registry may result in improved diagnosis, more effective treatments and possibly prevention.
Eligibility:
All patients with oncologic diagnoses are eligible for enrollment. Eligible cases will include patients or family members within families where at least one individual has been diagnosed with an eligible malignancy.
Time Commitment/Requirements:
Dependent upon diagnosis and specimens collected. Most specimens collected during a clinical visit.
Primary Investigator:
Dr. Shahab Asgharzadeh
Coordinator Contact Name:
Rebekah Kennedy
Phone Number:
323-361-5642
Email:
rekennedy@chla.usc.edu